Abstract
AIMS--To study the oesophageal histological changes in long term users of non-steroidal anti-inflammatory drugs (NSAIDs) compared with patients not receiving these drugs. METHODS--Ninety eight patients were studied, 53 of whom had taken NSAIDs for three years; 45 had not. Oesophageal biopsy specimens were taken from healthy-looking mucosa in the lower third of oesophagus. The papillary length, the thickness of the basal cell layer, and the intensity of cells infiltrating the epithelium were all assessed blind. RESULTS--The NSAID group included four (7%) cases of papillary elongation and two (4%) cases of basal cell hyperplasia, compared with 13 (29%; p < 0.01) and eight (18%; p < 0.02), respectively, in patients not taking NSAIDs. The total histological scores were also lower in patients treated with NSAIDs. CONCLUSION--Long term NSAID users have fewer oesophageal histological abnormalities than patients not receiving NSAIDs. Macroscopic damage related to NSAID use is, therefore, unlikely to require pre-existing histological oesophagitis for its development.
Full text
PDFImages in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barrier C. H., Hirschowitz B. I. Controversies in the detection and management of nonsteroidal antiinflammatory drug-induced side effects of the upper gastrointestinal tract. Arthritis Rheum. 1989 Jul;32(7):926–932. [PubMed] [Google Scholar]
- Bjarnason I., Hayllar J., MacPherson A. J., Russell A. S. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 1993 Jun;104(6):1832–1847. doi: 10.1016/0016-5085(93)90667-2. [DOI] [PubMed] [Google Scholar]
- Collins B. J., Elliott H., Sloan J. M., McFarland R. J., Love A. H. Oesophageal histology in reflux oesophagitis. J Clin Pathol. 1985 Nov;38(11):1265–1272. doi: 10.1136/jcp.38.11.1265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dennish G. W., Castell D. O. Inhibitory effect of smoking on the lower esophageal sphincter. N Engl J Med. 1971 May 20;284(20):1136–1137. doi: 10.1056/NEJM197105202842007. [DOI] [PubMed] [Google Scholar]
- Eastwood G. L., Beck B. D., Castell D. O., Brown F. C., Fletcher J. R. Beneficial effect of indomethacin on acid-induced esophagitis in cats. Dig Dis Sci. 1981 Jul;26(7):601–608. doi: 10.1007/BF01367672. [DOI] [PubMed] [Google Scholar]
- Eng J., Sabanathan S. Drug-induced esophagitis. Am J Gastroenterol. 1991 Sep;86(9):1127–1133. [PubMed] [Google Scholar]
- Feldman M., Colturi T. J. Effect of indomethacin on gastric acid and bicarbonate secretion in humans. Gastroenterology. 1984 Dec;87(6):1339–1343. [PubMed] [Google Scholar]
- Gibson T. Nonsteroidal anti-inflammatory drugs--another look. Br J Rheumatol. 1988 Apr;27(2):87–90. doi: 10.1093/rheumatology/27.2.87. [DOI] [PubMed] [Google Scholar]
- Janssens J., Vantrappen G. Pathophysiology of reflux esophagitis. Scand J Gastroenterol Suppl. 1989;156:15–19. doi: 10.3109/00365528909091033. [DOI] [PubMed] [Google Scholar]
- Levine R. A., Nandi J., King R. L. Nonsalicylate nonsteroidal antiinflammatory drugs augment prestimulated acid secretion in rabbit parietal cells. Investigation of the mechanisms of action. Gastroenterology. 1991 Sep;101(3):756–765. doi: 10.1016/0016-5085(91)90536-t. [DOI] [PubMed] [Google Scholar]
- Ottignon Y., Alber D., Moussard C., Deschamps J. P., Carayon P., Henry J. C. Esophageal mucosal prostaglandin E2 levels in health and in gastroesophageal reflux disease. Prostaglandins Leukot Med. 1987 Oct;29(2-3):141–151. doi: 10.1016/0262-1746(87)90003-5. [DOI] [PubMed] [Google Scholar]
- Roling G. T., Farrell R. L., Castell D. O. Cholinergic response of the lower esophageal sphincter. Am J Physiol. 1972 Apr;222(4):967–972. doi: 10.1152/ajplegacy.1972.222.4.967. [DOI] [PubMed] [Google Scholar]
- Santucci L., Patoia L., Fiorucci S., Farroni F., Favero D., Morelli A. Oesophageal lesions during treatment with piroxicam. BMJ. 1990 Apr 14;300(6730):1018–1018. doi: 10.1136/bmj.300.6730.1018-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shay S. S., Eggli D., McDonald C., Johnson L. F. Gastric emptying of solid food in patients with gastroesophageal reflux. Gastroenterology. 1987 Feb;92(2):459–465. doi: 10.1016/0016-5085(87)90142-9. [DOI] [PubMed] [Google Scholar]
- Shore S., Collier B., Martin J. G. Effect of endogenous prostaglandins on acetylcholine release from dog trachealis muscle. J Appl Physiol (1985) 1987 May;62(5):1837–1844. doi: 10.1152/jappl.1987.62.5.1837. [DOI] [PubMed] [Google Scholar]
- Skander M. P., Ryan F. P. Non-steroidal anti-inflammatory drugs and pain free peptic ulceration in the elderly. BMJ. 1988 Oct 1;297(6652):833–834. doi: 10.1136/bmj.297.6652.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stein B. E., Schwartzman M. L., Carroll M. A., Stahl R. E., Rosenthal W. S. Role of arachidonic acid metabolites in acid-pepsin injury to rabbit esophagus. Gastroenterology. 1989 Aug;97(2):278–283. doi: 10.1016/0016-5085(89)90062-0. [DOI] [PubMed] [Google Scholar]
- Taha A. S., Dahill S., Nakshabendi I., Lee F. D., Sturrock R. D., Russell R. I. Duodenal histology, ulceration, and Helicobacter pylori in the presence or absence of non-steroidal anti-inflammatory drugs. Gut. 1993 Sep;34(9):1162–1166. doi: 10.1136/gut.34.9.1162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taha A. S., Nakshabendi I., Lee F. D., Sturrock R. D., Russell R. I. Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration. J Clin Pathol. 1992 Feb;45(2):135–139. doi: 10.1136/jcp.45.2.135. [DOI] [PMC free article] [PubMed] [Google Scholar]